Percutaneous Plug-based Arteriotomy Closure Device Use in Minimally Invasive Cardiac Surgery
Study of a Plug-Based Device to Close a Groin Artery After Minimally Invasive Heart Surgery
Brief description of study
A single-center prospective study. Patients undergoing minimally invasive cardiac surgery between 2017 and 2022 at the Karolinska University Hospital in Stockholm, Sweden are eligible. Femoral cannulation was performed percutaneously with planned percutaneous arteriotomy closed using a plug-based arteriotomy closure device (MANTA; Teleflex/Essential Medical, Malvern, PA). Data regarding preoperative clinical characteristics and operative details were obtained by medical records review.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Minimally Invasive Cardiac Surgery
-
Age: 18 years or above
-
Gender: All
Inclusion Criteria:
- Operated with minimally invasive cardiac surgery between 2017 and 2022 at the Karolinska University Hospital in Stockholm, Sweden, with use of percutaneous femoral cannulation with planned percutaneous arteriotomy closed using a plug-based arteriotomy closure device.
Exclusion Criteria:
- None.
The purpose of this research study is to learn about the use of a plug-based device to close an opening in the femoral artery (a large artery in the groin) after minimally invasive heart surgery. The study is for people who had minimally invasive cardiac surgery at Karolinska University Hospital in Stockholm, Sweden between 2017 and 2022.
Participants will have had a minimally invasive heart surgery where the surgical team placed a tube into the femoral artery through the skin (percutaneous femoral cannulation). Participants will have had the artery opening closed through the skin using a plug-based closure device at the end of the procedure. The study team will collect information about participants’ health before surgery and details about the operation by reviewing medical records.
Who can participate:
People who had minimally invasive cardiac surgery at Karolinska University Hospital in Stockholm, Sweden may be able to participate if they:
- Had minimally invasive cardiac surgery between 2017 and 2022
- Had a tube placed into the femoral artery through the skin during surgery
- Had the artery opening closed through the skin using a plug-based closure device
Find a site
,
Send a message
Enter your contact details to connect with study team
Primary Contact
Interested in the study?
Select a study center that’s convenient for you, and get in touch with the study team.
Please choose between Voice or SMS based delivery of verification code
or